首页> 外文会议>Pacific Symposium on Biocomputing >SHARING INFORMATION TO RECONSTRUCT PATIENT-SPECIFIC PATHWAYS IN HETEROGENEOUS DISEASES
【24h】

SHARING INFORMATION TO RECONSTRUCT PATIENT-SPECIFIC PATHWAYS IN HETEROGENEOUS DISEASES

机译:分享信息以重建异质疾病中的患者特异性途径

获取原文

摘要

Advances in experimental techniques resulted in abundant genomic, transcriptomic, epigenomic, and proteomic data that have the potential to reveal critical drivers of human diseases. Complementary algorithmic developments enable researchers to map these data onto protein-protein interaction networks and infer which signaling pathways are perturbed by a disease. Despite this progress, integrating data across different biological samples or patients remains a substantial challenge because samples from the same disease can be extremely heterogeneous. Somatic mutations in cancer are an infamous example of this heterogeneity. Although the same signaling pathways may be disrupted in a cancer patient cohort, the distribution of mutations is long-tailed, and many driver mutations may only be detected in a small fraction of patients. We developed a computational approach to account for heterogeneous data when inferring signaling pathways by sharing information acrosg the samples. Our technique builds upon the prize-collecting Steiner forest problem, a network optimization algorithm that extracts pathways from a protein-protein interaction network. We recover signaling pathways that are similar across all samples yet still reflect the unique characteristics of each biological sample. Leveraging data from related tumors improves our ability to recover the disrupted pathways and reveals patient-specific pathway perturbations in breast cancer.
机译:实验技术的进展导致丰富的基因组,转录组,表观胶质和蛋白质组学数据,具有揭示人类疾病的关键驱动因素。互补算法的发展使研究人员能够将这些数据映射到蛋白质 - 蛋白质相互作用网络上,并推断出一种信号传导途径被疾病扰乱。尽管进行了这一进展,但在不同的生物样本或患者上整合数据仍然是一个大量挑战,因为来自同一疾病的样品可以是极其异质的。癌症中的细胞突变是这种异质性的臭虫的例子。尽管在癌症患者队列中可能破坏相同的信号通路,但是突变的分布是长尾的,并且许多驾驶员突变只能在一小部分患者中检测到。当通过共享信息ACROSG示例时,我们开发了一种计算方法来解释异构数据时的异构数据。我们的技术基于奖杯施泰林林问题,一种网络优化算法,其从蛋白质 - 蛋白质相互作用网络中提取途径。我们恢复所有样品中类似的信号通路仍然反映每个生物样本的独特特征。利用相关肿瘤的数据提高了我们恢复破坏途径的能力,并揭示了乳腺癌中患者特异性途径扰动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号